Patent · US Active

Vaccinia virus H3L and B5R specific monoclonal antibodies and methods of making and using same

US9447172B2 · kind B2 · utility

0Cited by

2References

19Claims

0Family size

Assignees

KYOWA HAKKO KIRIN CO., LTD. · JP
LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY · US

Inventors

Shinichiro Kato · Kariya, JP
Steve Granger · Encinitas, US
Shane Crotty · San Diego, US
Sandra Rickert · Encinitas, US
Lilia Koriazova · San Diego, US
Tomoyuki Tahara · Tokyo, JP

Key dates

Filing date	Dec 27, 2013
Grant date	Sep 20, 2016
Priority date	—
Expiry date	Jan 10, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/734
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to antibodies and subsequences thereof that specifically bind to poxvirus B5R envelope protein, antibodies and subsequences thereof that specifically bind to poxvirus H3L envelope protein, and combinations thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.